Drug Discovery Informatics Market size to Grow by USD 4,953.48 million from 2022 to 2027|Increasing R&D investments by pharmaceutical and biopharmaceutical companies drive the market - Technavio

NEW YORK, July 20, 2023 /PRNewswire/ -- The drug discovery informatics market size is estimated to increase by USD 4,953.48 million from 2022 to 2027. The market's growth momentum will progress at a CAGR of 15.06%. Discover some insights on market size historic period (2017 to 2021) and Forecast (2023 to 2027) before buying the full report -Request a sample report

Drug discovery informatics market – Vendor Analysis
Vendor Landscape - The global drug discovery informatics market is fragmented, with the presence of several global as well as regional vendors. A few prominent vendors that offer drug discovery informatics in the market are Aragen Life Sciences Pvt. Ltd., Certara Inc., Charles River Laboratories International Inc., ChemAxon Ltd., ChemBridge Corp., Collaborative Drug Discovery Inc., Cresset BioMolecular Discovery Ltd., Curia Global Inc., Dassault Systemes SE, Eurofins Scientific SE, Evotec SE, Infosys Ltd., Insilico Medicine, International Business Machines Corp., Jubilant Pharmova Ltd., Melissa Inc., OpenEye Scientific Software Inc., Perkin Elmer Inc., Schrodinger Inc., Selvita SA, and Thermo Fisher Scientific Inc. and others.

What's New? -

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
• Global competitiveness and key competitor positions
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - Buy the report!

Vendor Offerings -

• ChemAxon Ltd. - The company offers drug discovery informatics solutions such as KNIME workflow platform.
• Certara Inc. - The company offers drug discovery informatics solutions such as Phoenix PK PD, Pinnacle 21.
• Charles River Laboratories International Inc. - The company offers drug discovery informatics solutions such as Logica Transformative Drug Design.
• For details on the vendor and its offerings – Request a sample report

Drug Discovery Informatics Market - Segmentation Assessment
Segment Overview
Technavio has segmented the market based on application (discovery informatics and development informatics), solution (software and services), and geography (North America, Europe, Asia, and Rest of World (ROW)). 

• The market share growth by the discovery informatics segment will be significant during the forecast period. The drug discovery and development process heavily relies on the discovery of drug molecules targeted for specific therapeutic areas, making it a crucial stage. This involves generating a substantial amount of data and information. Two key steps in the process are identification and validation, as well as lead generation. Researchers primarily concentrate on early-stage lead generation across various target classes. Utilizing techniques like high-throughput screening, molecular modelling, medicinal chemistry, and structural biology, novel leads are identified and selectively guided through the preclinical discovery process. The drug discovery process is time-consuming and costly, which poses challenges for end users such as the pharmaceutical and biotechnology industries. Discovery informatics plays a significant role in efficiently processing large datasets, encompassing informatics for identification, validation, and assay development, as well as informatics for lead generation.

Geography Overview
By geography, the global drug discovery informatics market is segmented into North America, Europe, Asia, and the Rest of the World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global drug discovery informatics market.

·         North America is estimated to account for  29% of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The drug discovery informatics market in North America is expected to experience moderate growth. This region has witnessed a surge in the adoption of advanced technologies in recent years. Factors driving the market in North America include the adoption of advanced technology, the increasing prevalence of chronic and lifestyle diseases, government funding support for drug discovery, the presence of pharmaceutical and biopharmaceutical companies, and growing investments in information technology. Moreover, the market in North America is propelled by the increasing presence of leading vendors and the growing adoption of AI and machine learning in drug discovery informatics

For insights on global, regional, and country-level parameters with growth opportunities from 2017 to 2027 - Download a Sample Report

Drug Discovery Informatics Market – Market Dynamics

The increasing R&D investments by pharmaceutical and biopharmaceutical companies are notably driving the drug discovery informatics market growth. Due to the rising prevalence and incidence of chronic diseases such as diabetes, COPD, asthma, cancer, heart disease, arthritis, cystic fibrosis, and dementia, there is a growing demand for the development of drugs. Pharmaceutical and biopharmaceutical companies are increasingly focusing on research and development (R&D) activities to expand their drug pipelines for various therapeutic applications. They are investing in innovative medicines in areas like immunology, cancer, and infectious diseases to enhance their product portfolios. The pharmaceutical industry allocates a significant portion of its revenue, approximately 65% for early-stage discovery and development and 35% for late-stage development. Drug discovery informatics plays a crucial role in supporting the R&D process and speeding up product development. As a result, the demand for advanced software solutions in the drug discovery informatics market is growing.

An increasing number of clinical trials is an emerging trend shaping market growth.  Pharmaceutical companies, biotechnology companies, and research institutes prioritize clinical trials as a crucial step in developing new treatments for chronic and infectious diseases. Clinical trials provide essential information about the safety and effectiveness of new drug molecules and are necessary for regulatory approval and marketing. However, collecting and managing clinical trial data can be complex and costly. An efficient clinical data integration platform enables real-time integration, standardization, and aggregation of data from various source systems. This platform facilitates early decision-making for pharmaceutical companies regarding drug molecules. Drug discovery informatics solutions play a vital role in optimizing clinical trial performance, and vendors in the market are focused on developing clinical trial management solutions. These factors contribute to the growth of the drug discovery informatics market during the forecast period.

The high setup costs of drug discovery informatics are the significant challenge hindering market growth. Drug discovery and development involve handling extensive data and information. Pharmaceutical and biopharmaceutical companies utilize drug discovery informatics to integrate and aggregate diverse and distributed data. The drug discovery and design process is financially demanding due to the high costs associated with research and development as well as clinical trials, which can range from USD 800 million to USD 2 billion on average. Drug discovery informatics plays a pivotal role in expediting the drug development journey, encompassing target identification to commercialization. Computational drug design (CADD) necessitates suitable facilities for designing, developing, and optimizing bioactive compounds. The cost of pharmaceutical research informatics influences its adoption in research laboratories, which can be influenced by factors such as software costs, technical staff expenses, and advanced equipment expenditures. Utilizing software as a service (SAAS), high-throughput screening (HTS) software, and laboratory information management systems (LIMS) in drug discovery and development contributes to the overall expenses of drug discovery informatics. The high costs associated with the entire drug discovery process restrict the use of drug discovery informatics solutions in small and medium-sized laboratories, posing a potential hindrance to the growth of the drug discovery informatics market during the forecast period.

 Drivers, Trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report! 
 

What are the key data covered in this Drug Discovery Informatics Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the drug discovery informatics market between 2023 and 2027
• Precise estimation of the drug discovery informatics market size and its contribution to the market in focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the drug discovery informatics market industry across North America, Europe, Asia, and the Rest of the World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of drug discovery informatics market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The drug screening market size is estimated to grow at a CAGR of 16.97% between 2022 and 2027. The market size is forecast to increase by USD 6,659.87 million. This report extensively covers market segmentation by type (drug screening products and drug screening services), application (urine samples, breath samples, hair and blood samples, and oral fluid samples), and geography (North America, Europe, Asia, and the Rest of the World (ROW).  Advancements in drug screening technologies is notably driving the market growth.

The RNAi drug delivery market size is estimated to grow at a CAGR of 20.83% between 2022 and 2027. The market size is forecast to increase by USD 109.73 billion. This report extensively covers market segmentation by technology (nanoparticle drug delivery, pulmonary drug delivery, nucleic acid drug delivery, and aptamer drug delivery), application (infectious diseases, oncology, cardiology, neurology, and others), and geography (North America, Europe, Asia, and Rest of World (ROW) ). The increasing R&D for RNAi therapy by vendors is the primary trend in the RNAi drug delivery market. 

Table of contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Solution
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022 

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global drug discovery informatics market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on Global drug discovery informatics market 2017 - 2021 ($ million)

• 4.2 Application Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)

• 4.3 Solution Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – Solution Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments 
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)

• 6.2 Comparison by Application 
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application

• 6.3 Discovery informatics - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Discovery informatics - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Discovery informatics - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Discovery informatics - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Discovery informatics - Year-over-year growth 2022-2027 (%)

• 6.4 Development informatics - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Development informatics - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Development informatics - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Development informatics - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Development informatics - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Application 
• Exhibit 42: Market opportunity by Application ($ million)
• Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Solution

• 7.1 Market segments 
• Exhibit 44: Chart on Solution - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Solution - Market share 2022-2027 (%)

• 7.2 Comparison by Solution 
• Exhibit 46: Chart on Comparison by Solution
• Exhibit 47: Data Table on Comparison by Solution

• 7.3 Software - Market size and forecast 2022-2027
• Exhibit 48: Chart on Software - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Software - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Software - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Software - Year-over-year growth 2022-2027 (%)

• 7.4 Services - Market size and forecast 2022-2027
• Exhibit 52: Chart on Services - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Services - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Services - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Services - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by Solution 
• Exhibit 56: Market opportunity by Solution ($ million)
• Exhibit 57: Data Table on Market opportunity by Solution ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 59: Chart on Market share by geography 2022-2027 (%)
• Exhibit 60: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.10 France - Market size and forecast 2022-2027
• Exhibit 91: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.11 China - Market size and forecast 2022-2027
• Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 99: Market opportunity by geography ($ million)
• Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers 

• 10.2 Market challenges 

• 10.3 Impact of drivers and challenges 
• Exhibit 101: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends 

11 Vendor Landscape

• 11.1 Overview 

• 11.2 Vendor landscape 
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 103: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 105: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 106: Matrix on vendor position and classification

• 12.3 Certara Inc. 
• Exhibit 107: Certara Inc. - Overview
• Exhibit 108: Certara Inc. - Product / Service
• Exhibit 109: Certara Inc. - Key news
• Exhibit 110: Certara Inc. - Key offerings

• 12.4 Charles River Laboratories International Inc.
• Exhibit 111: Charles River Laboratories International Inc. - Overview
• Exhibit 112: Charles River Laboratories International Inc. - Business segments
• Exhibit 113: Charles River Laboratories International Inc. - Key news
• Exhibit 114: Charles River Laboratories International Inc. - Key offerings
• Exhibit 115: Charles River Laboratories International Inc. - Segment focus

• 12.5 ChemAxon Ltd. 
• Exhibit 116: ChemAxon Ltd. - Overview
• Exhibit 117: ChemAxon Ltd. - Product / Service
• Exhibit 118: ChemAxon Ltd. - Key offerings

• 12.6 ChemBridge Corp. 
• Exhibit 119: ChemBridge Corp. - Overview
• Exhibit 120: ChemBridge Corp. - Product / Service
• Exhibit 121: ChemBridge Corp. - Key offerings

• 12.7 Collaborative Drug Discovery Inc. 
• Exhibit 122: Collaborative Drug Discovery Inc. - Overview
• Exhibit 123: Collaborative Drug Discovery Inc. - Product / Service
• Exhibit 124: Collaborative Drug Discovery Inc. - Key offerings

• 12.8 Cresset BioMolecular Discovery Ltd.
• Exhibit 125: Cresset BioMolecular Discovery Ltd. - Overview
• Exhibit 126: Cresset BioMolecular Discovery Ltd. - Product / Service
• Exhibit 127: Cresset BioMolecular Discovery Ltd. - Key offerings

• 12.9 Curia Global Inc. 
• Exhibit 128: Curia Global Inc. - Overview
• Exhibit 129: Curia Global Inc. - Product / Service
• Exhibit 130: Curia Global Inc. - Key news
• Exhibit 131: Curia Global Inc. - Key offerings

• 12.10 Dassault Systemes SE 
• Exhibit 132: Dassault Systemes SE - Overview
• Exhibit 133: Dassault Systemes SE - Product / Service
• Exhibit 134: Dassault Systemes SE - Key news
• Exhibit 135: Dassault Systemes SE - Key offerings

• 12.11 Evotec SE 
• Exhibit 136: Evotec SE - Overview
• Exhibit 137: Evotec SE - Business segments
• Exhibit 138: Evotec SE - Key news
• Exhibit 139: Evotec SE - Key offerings
• Exhibit 140: Evotec SE - Segment focus

• 12.12 Infosys Ltd. 
• Exhibit 141: Infosys Ltd. - Overview
• Exhibit 142: Infosys Ltd. - Business segments
• Exhibit 143: Infosys Ltd. - Key news
• Exhibit 144: Infosys Ltd. - Key offerings
• Exhibit 145: Infosys Ltd. - Segment focus

• 12.13 International Business Machines Corp.
• Exhibit 146: International Business Machines Corp. - Overview
• Exhibit 147: International Business Machines Corp. - Business segments
• Exhibit 148: International Business Machines Corp. - Key offerings
• Exhibit 149: International Business Machines Corp. - Segment focus

• 12.14 Jubilant Pharmova Ltd. 
• Exhibit 150: Jubilant Pharmova Ltd. - Overview
• Exhibit 151: Jubilant Pharmova Ltd. - Business segments
• Exhibit 152: Jubilant Pharmova Ltd. - Key news
• Exhibit 153: Jubilant Pharmova Ltd. - Key offerings
• Exhibit 154: Jubilant Pharmova Ltd. - Segment focus

• 12.15 Melissa Inc. 
• Exhibit 155: Melissa Inc. - Overview
• Exhibit 156: Melissa Inc. - Product / Service
• Exhibit 157: Melissa Inc. - Key offerings

• 12.16 OpenEye Scientific Software Inc. 
• Exhibit 158: OpenEye Scientific Software Inc. - Overview
• Exhibit 159: OpenEye Scientific Software Inc. - Product / Service
• Exhibit 160: OpenEye Scientific Software Inc. - Key offerings

• 12.17 Perkin Elmer Inc. 
• Exhibit 161: Perkin Elmer Inc. - Overview
• Exhibit 162: Perkin Elmer Inc. - Business segments
• Exhibit 163: Perkin Elmer Inc. - Key news
• Exhibit 164: Perkin Elmer Inc. - Key offerings
• Exhibit 165: Perkin Elmer Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 166: Inclusions checklist
• Exhibit 167: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 168: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 169: Research methodology
• Exhibit 170: Validation techniques employed for market sizing
• Exhibit 171: Information sources

• 13.5 List of abbreviations 
• Exhibit 172: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio